Development and Clinical Validation of Ketogen-based Therapeutic Diet for Pancreaticobiliary Cancer Patients
1 other identifier
interventional
30
1 country
1
Brief Summary
Decreased bowel function and loss of appetite in patients who underwent pancreaticobiliary surgery contribute impaired nutritional status in postoperative period. It can also affect perioperative and oncologic outcomes negatively. Therefore it is important to improve nutritional status in postoperative period by supply tailor-made optimal diets. The investigators have developed customized postoperative diets for pancreaticobiliary cancer patients. The investigators expect that customized diets for pancreaticobiliary patients will increase the food intake rate and contribute a improvement of perioperative outcomes and even oncologic outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2016
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 7, 2016
CompletedFirst Submitted
Initial submission to the registry
November 13, 2016
CompletedFirst Posted
Study publicly available on registry
November 16, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2017
CompletedMarch 15, 2018
March 1, 2018
11 months
November 13, 2016
March 13, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Food Intake Rate(%) for postoperative diet
Diet Intake Rate(%) will be examined by dietary satisfaction questionnaires.
3 days after the diet
Study Arms (3)
Ordinary Diet
OTHEROrdinary Diet
Modified Atkin's Diet
OTHERModified Atkin's Diet
Ketogenic Diet
OTHERKetogenic Diet
Interventions
Eligibility Criteria
You may qualify if:
- Adult (age more than 19)
- Pancreaticobiliary cancer patient who is scheduled pancreaticoduodenectomy or distal pancreatectomy
- Pancreatic cancer / Duodenal cancer / Distal bile duct cancer / Ampulla of Vater cancer
You may not qualify if:
- Patient who denied clinical trial
- Diabetes Mellitus(DM) patient with DM complication
- Hyperlipidemia patient with vascular co-morbidity
- Impaired renal function or renal failure (GFP\<90%)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Severance Hospital
Seoul, 120-752, South Korea
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 13, 2016
First Posted
November 16, 2016
Study Start
November 7, 2016
Primary Completion
October 1, 2017
Study Completion
October 1, 2017
Last Updated
March 15, 2018
Record last verified: 2018-03
Data Sharing
- IPD Sharing
- Will not share